For patients with nonvalvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use ...

An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.

For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...

The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and ...

A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help ...

In patients with atrial fibrillation, those assigned left atrial appendage closure had similar ischemic outcomes and better bleeding outcomes compared with those assigned oral anticoagulation, ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...

Higher left atrial end-systolic dimension (LASD), an increased measurement of the left upper chamber of the heart, and left ...

Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial fibrilla ...

News from ACC 2026 dominates our most-read list, along with the dyslipidemia guidelines, Lp(a) vs CAC, and apixaban for VTE.

Boston presented the pair of trial readouts at the 2026 American College of Cardiology (ACC) conference in New Orleans.